3 employees
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria.
2021
$1.3M
from 1 investors over 1 rounds
smartbax GmbH raised $1.3M on May 23, 2023
Investors: High-Tech Gründerfonds